Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2020-02-07 · DEPARTMENT OF HEALTH AND HUMAN SERVICES · Notices

Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

547 words·~2 min read·/register/2020/02/07/2020-02403

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel;
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder. *Date:* March 5, 2020. *Time:* 12:00 p.m. to 3:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, National Science Center, 6001 Executive Boulevard, Room 4238, Rockville, MD 20852 (Telephone Conference Call). *Contact Person:* Hiromi Ono, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, *hiromi.ono@nih.gov* . *Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel;
NIDA Core and Research Center of Excellence Grant Program (P30/50 Clinical Trial Optional). *Date:* March 9-10, 2020. *Time:* 8:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Courtyard Marriott Bethesda Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. *Contact Person:* Yvonne Owens Ferguson, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 4234, Bethesda, MD 20892, 301-402-7371, *yvonne.ferguson@nih.gov* . *Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel;
NIH Pathway to Independence Award (K99/R00). *Date:* March 19, 2020. *Time:* 1:00 p.m. to 4:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, National Science Center, 6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone Conference Call). *Contact Person:* Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 4245, Rockville, MD 20852, 301-435-1426, *mcguireso@mail.nih.gov* . *Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel;
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed). *Date:* April 6, 2020. *Time:* 1:00 p.m. to 2:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, National Science Center, 6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone Conference Call). *Contact Person:* Susan O. McGuire, Ph.D., Scientific Review Officer Office, of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 4245, Rockville, MD 20852, 301-435-1426, *mcguireso@mail.nih.gov* .
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: February 3, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020-02403 Filed 2-6-20; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.